FTC Urges 2nd Circ. To Overturn Tamoxifen Precedent

Law360, New York (May 26, 2010, 4:22 PM EDT) -- The Federal Trade Commission has urged a federal appeals court to grant an en banc rehearing in a lawsuit over a “pay-for-delay” deal Bayer AG cut with Barr Laboratories Inc. to prevent the generic-drug maker from making its own version of the blockbuster antibiotic Cipro.

The FTC said Tuesday it voted 5-0 to approve the filing of an amicus brief on the side of the plaintiffs in the case, a group of direct purchasers.

The brief, filed May 20 in the U.S. Court of Appeals for...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.